antibody VRC01, broadly neutralizing antibody, HIV-1 envelope trimer, polyreactivity, prophylaxis, treatment
Intranasal SARS-CoV-2 vaccine, parainfluenza virus vector vaccine, live-attenuated vaccine for intranasal delivery, pediatric COVID-19 vaccine
HIV-1, envelope, vaccine, neutralizing antibodies, precursor lineage, structure-guided design, chimeric trimer, knock-in mouse